Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,434 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma

NCT02594384

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Winship Cancer Institute at Emory University Atlanta, Georgia, United States
  • Horizon Oncology Research, Inc. Lafayette, Indiana, United States
View Trial Details
Completed

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

NCT04450069

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

NCT04204057

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • University Multiprofile Hospital for Active Treatment "Dr Georgi Stranski" Ltd., Pleven, Bulgaria
  • University Multiprofile Hospital for Active Treatment "Sv Ivan Rilski" Ltd Sofia, Bulgaria
  • Ltd. M.Zodelava Hematology Centre Tbilisi, Georgia
  • Medivest - Institute of Hematology and Transfusiology Tbilisi, Georgia
View Trial Details
Completed

A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy

NCT03406156

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +17 more
Locations
  • Arizona Oncology Associates, PC-HOPE /ID# 202335 Tempe, Arizona, United States
  • Rocky Mountain Cancer Centers - Denver Midtown /ID# 202328 Denver, Colorado, United States
  • MidAmerica Division, Inc. /ID# 201099 Kansas City, Missouri, United States
  • Oncology Hematology Care, Inc. /ID# 202397 Cincinnati, Ohio, United States
View all 15 locations
View Trial Details
Completed

A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT04434196

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Local Institution - 106 Boston, Massachusetts, United States
  • Local Institution - 104 Columbus, Ohio, United States
  • Local Institution - 101 Portland, Oregon, United States
  • Local Institution - 107 Dallas, Texas, United States
View all 15 locations
View Trial Details

Related conditions